Trek Financial, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1768195 Scottsdale, AZ

Position in GILD

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$2,077,029

+$1,696,271 QoQ

Shares Held

16,440

+501.8% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.27%

of 13F equity value

Holder Rank

#819

of 2,266 holders

Holding Since

Dec 2021

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Trek Financial, LLC holds $22,596,486 across 11 Drug Manufacturers - General names. GILD ranks #4 (9.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	39,151	$9,943,179
2	LLY	ELI LILLY & Co	3,679	$4,412,703
3	AMGN	Amgen Inc	7,005	$2,536,650
4	GILD	Gilead Sciences, Inc. This page	16,440	$2,077,029
5	MRK	Merck & Co., Inc.	8,583	$1,102,915
6	ABBV	AbbVie Inc.	3,156	$794,175
7	NVO	Novo Nordisk A S	10,744	$515,067
8	NVS	Novartis AG	2,210	$346,351

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,077,029	16,440	+501.8%	Shares	Sole	2026-08-13
2026-03-31	$380,758	2,732	-82.5%	Shares	Sole	2026-05-13
2025-12-31	$1,914,007	15,594	+510.8%	Shares	Sole	2026-02-04
2025-09-30	$283,383	2,553	-41.1%	Shares	Sole	2025-10-31
2024-06-30	$297,218	4,332	-22.8%	Shares	Sole	2024-08-12
2024-03-31	$411,005	5,611	-20.4%	Shares	Sole	2024-05-14
2023-12-31	$571,363	7,053	-17.6%	Shares	Sole	2024-02-08
2023-09-30	$641,561	8,561	-3.4%	Shares	Sole	2023-11-14
2023-06-30	$683,148	8,864	-10.9%	Shares	Sole	2023-08-14
2023-03-31	$824,970	9,943	+49.8%	Shares	Sole	2023-05-12
2022-12-31	$569,872	6,638	-1.9%	Shares	Sole	2023-02-13
2022-09-30	$417,332	6,765	-43.2%	Shares	Sole	2022-11-14
2022-06-30	$735,848	11,905	+0.3%	Shares	Sole	2022-08-10
2022-03-31	$705,671	11,870	+24.4%	Shares	Sole	2022-05-10
2021-12-31	$692,699	9,540	—	Shares	Sole	2022-01-19
No filing history on record for this holder in this stock.